About Nova Biomedical
Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,200 people, with sales and service subsidiaries in eight countries and distributors in more than 91 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts; and Taipei, Taiwan. Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.

Worldwide Market Areas Include:
Hospital Blood Gas and Critical Care Analyzers
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.

Pioneering Technological Innovations
Nova Biomedical has a 40-year history as the world leader in developing whole blood biosensors for clinical and cell culture/fermentation use.

A Global Company
Nova has sales and service operations in 100 countries through Nova subsidiaries or distributors. Nova’s wholly-owned subsidiaries are located in Brazil, Canada, France, Germany, the UK, Japan, Italy, Spain, Switzerland, and the US, with distributors in 92 additional countries. Nova subsidiaries and distributors provide product information, demonstrations, local product inventory, and complete technical support. Whether you are located in North America, Europe, Russia, Eastern Europe, the Middle East, Africa, Asia, the Pacific Islands, Latin America, or the Indian Subcontinent, Nova can support your point-of-care and critical care testing needs. Nova’s global manufacturing operations take place in four facilities certified by the International Organization for Standardization (ISO) and are located in Waltham and Billerica, Massachusetts, USA and Taipei, Taiwan. These facilities occupy a total of 420,000 square feet (42,000 square meters) of manufacturing space.

Measurement Technologies Used by Nova Analyzers
Potentiometric (whole blood or plasma), Amperometric (whole blood/plasma or cell culture media), Conductivity (whole blood), Immunochemistry (whole blood or plasma), Spectrophotometric (plasma and cell culture media), Photometric (lysed whole blood), Ellipsometry (saliva/urine), and Imaging (cell culture)

Events

Events not available

News

ICU Management

New Laboratory Blood Glucose Reference Analyzer from Nova Biomedical

2020 07 Nov

Nova Biomedical announces the availability of Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer. Nova Primary fills the need for a new glucose reference analyzer to replace the YSI STAT PLUS 2300 Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH). Manufacturers of blood glucose measuring devices and clinical... Read more

ICU Management

Nova Blood Gas Analyzers Add Important New Test – Estimated Plasma Volume

2020 01 Nov

Nova Biomedical announces the addition of a key new test to its Stat Profile Prime Plus critical care analyzer—the ability to calculate and report estimated plasma volume (ePV), a very important test for critically ill patients but one that has been very difficult to obtain. The plasma volume status of a patient is one of the top priorities in evaluating... Read more

ICU Management

Nova Biomedical Launches Allegro CRP Test in CE Regulated Countries

2020 05 Oct

Nova Biomedical announces the addition of C-reactive protein (CRP) testing to its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings. The Allegro and its StatStrip companion meter provides 11 clinically important tests to help physicians make therapeutic decisions and adjustments during the patient visit. The... Read more

Jobs not available

Catalogue

    Catalogue not available

200 Prospect Street,
Waltham, Massachusetts
MA 02454-9141
United States
(781) 894-0800

White Papers - Case Studies

ICU Management

Why Should We Be Measuring Ionized Magnesium?

2021 11 Feb

Dennis Begos , MD, FACS, FACRS Associate Director, Medical and Scientific Affairs Nova Biomedical Magnesium in the Human Body Magnesium (Mg) is the 4th most abundant cation in the human body. The majority of it is found intracellularly, more than half in bone, about a third in muscle, and the remaining in soft tissue and... Read more

Videos

    Videos not available

Articles

Not available

Blog

Not available

Find Nova Biomedical on Social Media